Xinyue Lian

613 total citations
16 papers, 427 citations indexed

About

Xinyue Lian is a scholar working on Hematology, Molecular Biology and Epidemiology. According to data from OpenAlex, Xinyue Lian has authored 16 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Xinyue Lian's work include Acute Myeloid Leukemia Research (9 papers), Inflammatory Myopathies and Dermatomyositis (6 papers) and Epigenetics and DNA Methylation (3 papers). Xinyue Lian is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Inflammatory Myopathies and Dermatomyositis (6 papers) and Epigenetics and DNA Methylation (3 papers). Xinyue Lian collaborates with scholars based in China, Canada and United States. Xinyue Lian's co-authors include Chunde Bao, Qiong Fu, Liangjing Lu, Qiang Guo, Jiang Lin, Sheng Chen, Jun Qian, Zhihui Zhang, Jing‐dong Zhou and Xiang‐mei Wen and has published in prestigious journals such as Nature Communications, PLoS ONE and CHEST Journal.

In The Last Decade

Xinyue Lian

15 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinyue Lian China 12 233 162 152 110 85 16 427
L. Burke United States 8 80 0.3× 111 0.7× 67 0.4× 45 0.4× 117 1.4× 11 374
Toshiaki Tsukada Japan 11 67 0.3× 122 0.8× 115 0.8× 30 0.3× 50 0.6× 20 320
Anna Tassidou Greece 8 55 0.2× 106 0.7× 184 1.2× 67 0.6× 23 0.3× 13 482
Judith Wienke Netherlands 12 125 0.5× 103 0.6× 124 0.8× 21 0.2× 16 0.2× 25 490
Eumorphia Maria Delicha United States 8 73 0.3× 248 1.5× 25 0.2× 131 1.2× 50 0.6× 17 415
Karena Pryce Australia 5 48 0.2× 506 3.1× 169 1.1× 208 1.9× 25 0.3× 6 765
Iris Amitay‐Laish Israel 10 89 0.4× 52 0.3× 50 0.3× 81 0.7× 13 0.2× 25 348
Lénaïg Mescam-Mancini France 6 111 0.5× 48 0.3× 120 0.8× 9 0.1× 106 1.2× 8 307
Ulrich Broeckel United States 5 46 0.2× 72 0.4× 270 1.8× 62 0.6× 14 0.2× 7 380
Lauris Gastaud France 12 47 0.2× 27 0.2× 64 0.4× 79 0.7× 74 0.9× 36 395

Countries citing papers authored by Xinyue Lian

Since Specialization
Citations

This map shows the geographic impact of Xinyue Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyue Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyue Lian more than expected).

Fields of papers citing papers by Xinyue Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyue Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyue Lian. The network helps show where Xinyue Lian may publish in the future.

Co-authorship network of co-authors of Xinyue Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyue Lian. A scholar is included among the top collaborators of Xinyue Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyue Lian. Xinyue Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lian, Xinyue, Chengqiang Xia, Zhiwei Chen, et al.. (2025). Muscle Visualization and Evaluation Methods for Immune Checkpoint Inhibitor-Related Myositis. Journal of Visualized Experiments.
2.
Lian, Xinyue, Yan Ye, Jing Zou, et al.. (2022). Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease. Lara D. Veeken. 62(5). 1910–1919. 9 indexed citations
3.
Ye, Yan, Zechuan Chen, Shan Jiang, et al.. (2022). Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications. Nature Communications. 13(1). 6458–6458. 60 indexed citations
4.
5.
Lian, Xinyue, Jing Zou, Qiang Guo, et al.. (2020). Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease. CHEST Journal. 158(4). 1535–1545. 91 indexed citations
6.
Xu, Antao, Yan Ye, Qiong Fu, et al.. (2020). Prognostic values of anti-Ro52 antibodies in anti-MDA5-positive clinically amyopathic dermatomyositis associated with interstitial lung disease. Lara D. Veeken. 60(7). 3343–3351. 69 indexed citations
7.
Li, Xixi, Jing‐dong Zhou, Xiang‐mei Wen, et al.. (2019). <p>Increased <em>MCL-1</em> expression predicts poor prognosis and disease recurrence in acute myeloid leukemia</p>. OncoTargets and Therapy. Volume 12. 3295–3304. 32 indexed citations
8.
Zhang, Zhihui, et al.. (2019). [Clinical Study of SCIN Expression and Dromoter Methylation in Patients with Chronic Myeloid Leukemia].. PubMed. 27(3). 646–651. 1 indexed citations
9.
Zhang, Zhihui, Wei Zhang, Jing‐dong Zhou, et al.. (2018). Decreased SCIN expression, associated with promoter methylation, is a valuable predictor for prognosis in acute myeloid leukemia. Molecular Carcinogenesis. 57(6). 735–744. 11 indexed citations
10.
Lian, Xinyue, Wei Zhang, Ji‐chun Ma, et al.. (2018). Methylation‐independent ITGA2 overexpression is associated with poor prognosis in de novo acute myeloid leukemia. Journal of Cellular Physiology. 233(12). 9584–9593. 17 indexed citations
11.
Lian, Xinyue, Ji‐chun Ma, Jing‐dong Zhou, et al.. (2018). Hypermethylation of ITGBL1 is associated with poor prognosis in acute myeloid leukemia. Journal of Cellular Physiology. 234(6). 9438–9446. 10 indexed citations
12.
Xu, Zi‐jun, Jing‐dong Zhou, Xi-xi Li, et al.. (2017). Methylation‐associated DOK1 and DOK2 down‐regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia. Journal of Cellular Physiology. 233(9). 6604–6614. 15 indexed citations
13.
Zhang, Ting‐juan, Jing‐dong Zhou, Dongqin Yang, et al.. (2017). TET2 expression is a potential prognostic and predictive biomarker in cytogenetically normal acute myeloid leukemia. Journal of Cellular Physiology. 233(8). 5838–5846. 25 indexed citations
14.
Zhang, Zhihui, Xinyue Lian, Dong‐ming Yao, et al.. (2017). Reduced intensity conditioning of allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia in patients older than 50 years of age: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 143(9). 1853–1864. 11 indexed citations
15.
Zhou, Jing‐dong, Dong‐ming Yao, Ji‐chun Ma, et al.. (2017). Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis. Oncotarget. 8(25). 41498–41507. 47 indexed citations
16.
Lian, Xinyue, Zhihui Zhang, Zhaoqun Deng, et al.. (2016). Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis. PLoS ONE. 11(11). e0165948–e0165948. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Burke Breakdown of academic impact, for papers by Toshiaki Tsukada Breakdown of academic impact, for papers by Anna Tassidou Breakdown of academic impact, for papers by Judith Wienke Breakdown of academic impact, for papers by Eumorphia Maria Delicha Breakdown of academic impact, for papers by Karena Pryce Breakdown of academic impact, for papers by Iris Amitay‐Laish Breakdown of academic impact, for papers by Lénaïg Mescam-Mancini Breakdown of academic impact, for papers by Ulrich Broeckel Breakdown of academic impact, for papers by Lauris Gastaud
Rankless by CCL
2026